These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6258827)

  • 1. Radioimmunoassay of extracted glucagon compared with three non-extraction assays.
    von Schenck H; Nilsson OR
    Clin Chim Acta; 1981 Jan; 109(2):183-91. PubMed ID: 6258827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon radioimmunoassay with use of antiserum to glucagon C-terminal fragment.
    Nishino T; Kodaira T; Shin S; Imagawa K; Shima K; Kumahara Y; Yanaihara C; Yanaihara N
    Clin Chem; 1981 Oct; 27(10):1690-7. PubMed ID: 6169468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon radioimmunoassay using antiserum 30K: interference by plasma.
    Weir GC; Turner RC; Martin DB
    Horm Metab Res; 1973 Jul; 5(4):241-4. PubMed ID: 4731271
    [No Abstract]   [Full Text] [Related]  

  • 4. Discrepancy of fasting plasma glucagon levels measured by different glucagon antisera.
    Tahara Y; Tanaka A; Yamamoto Y; Fukuda M; Kumahara Y; Shima K
    Diabetes Res; 1988 Apr; 7(4):179-83. PubMed ID: 3402167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased specificity of plasma glucagon radioimmunoassay by use of acetone extraction.
    von Schenck H
    Clin Chim Acta; 1983 Jan; 127(1):41-6. PubMed ID: 6825309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin G can cross-react with glucagon antisera and cause a spuriously high plasma immunoreactive glucagon level.
    Hattori N; Saiki Y; Kajikawa M; Ishihara T; Moridera K; Hino M; Ikekubo K; Kurahachi H
    Endocr J; 1995 Aug; 42(4):455-60. PubMed ID: 8556050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximal stimulation of pancreatic islet B-cells, and A-cell response to arginine, in dogs with longterm pancreatic acinar atrophy.
    Meister R; Berger I; Schwille PO; Gebhardt C
    Eur J Surg; 1991 May; 157(5):333-40. PubMed ID: 1678647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The normal range of the plasma immunoreactive glucagon level during a 75 g oral glucose tolerance test.
    Shima K; Hirota M; Nakamura K; Kodaira T
    Diabetes Res Clin Pract; 1985-1986 Feb; 1(5):265-71. PubMed ID: 3841774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma pancreatic glucagon in pancreatic and primary diabetes, and liver cirrhosis: application of a correction to the radioimmunoassay for pancreatic glucagon.
    Okumura N; Hayakawa T; Yasui K; Noda A; Kondo T; Otsuka K; Nimura Y
    Gastroenterol Jpn; 1982; 17(4):347-52. PubMed ID: 7141199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of a specific antiserum by synthetic C-terminal fragment of glucagon.
    Ohneda A; Watanabe K; Wakimatsu M; Fujino M
    Horm Metab Res; 1979 Aug; 11(8):463-8. PubMed ID: 574120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Big plasma glucagon in patients with liver cirrhosis. The discrepancy in values of immunoreactive glucagon measured by use of two different antisera against pancreatic glucagon, 30K and OAL-123].
    Tsubouchi H; Kamibeppu A; Fujisaki K; Oka H; Miyazaki H; Hirono S; Hashimoto S; Nagahama J; Gohda E; Daikuhara Y
    Nihon Shokakibyo Gakkai Zasshi; 1984 May; 81(5):1208-13. PubMed ID: 6471533
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of a "big plasma glucagon" response during arginine stimulation of glucagon secretion.
    von Schenck H; Vasquez B; Unger RH
    Horm Metab Res; 1982 Feb; 14(2):69-71. PubMed ID: 7068099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay for pancreatic glucagon based on specific derivatisation of the hormone.
    Nooijen WJ; Koppert PW
    Ann Clin Biochem; 1981 Mar; 18 (Pt 2)():118-22. PubMed ID: 6167195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a sensitive and specific radioimmunoassay for pancreatic glucagon in human plasma and its clinical application.
    Borghi VC; Wajchenberg BL; Albuquerque RH
    Clin Chim Acta; 1984 Jan; 136(1):39-48. PubMed ID: 6692564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice.
    Salehi A; Dornonville de la Cour C; Håkanson R; Lundquist I
    Regul Pept; 2004 May; 118(3):143-50. PubMed ID: 15003830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis.
    O'Brien TD; Hayden DW; Johnson KH; Stevens JB
    Vet Pathol; 1985 May; 22(3):250-61. PubMed ID: 3890345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of an antiserum against pancreatic glucagon.
    Von Schenck H
    Clin Chim Acta; 1977 Nov; 80(3):455-63. PubMed ID: 912916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific radioimmunoassay of pancreatic glucagon. Results in new-born and in child (author's transl)].
    Ruitton A; Frederich F
    Diabete Metab; 1975 Sep; 1(3):143-50. PubMed ID: 1234577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.